Abstract
Ageing and skin exposure to UV radiation induces production and activation of matrix metalloproteinases (MMPs) and human neutrophil elastase (HNE). These enzymes are known to break down the extracellular matrix (ECM) which leads to wrinkle formation. Here, we demonstrated the potential of a solid-in-oil nanodispersion containing a competitive inhibitor peptide of HNE mixed with hyaluronic acid (HA), displaying 158 nm of mean diameter, to protect the skin against the ageing effects. Western blot analysis demonstrated that activation of MMP-1 in fibroblasts by HNE treatment is inhibited by the solid-in-oil nanodispersion containing the peptide and HA. The results clearly demonstrate that solid-in-oil nanodispersion containing the HNE inhibitor peptide is a promising strategy for anti-ageing effects. This effect can be seen particularly by ECM regulation by affecting fibroblasts. The formulation also enhances the formation of thicker bundles of actin filaments.
Keywords: Diffusion, immunoassay, protease, inhibitory peptide, nanodispersion, proteolysis.
Protein & Peptide Letters
Title:Assessment of a Protease Inhibitor Peptide for Anti-Ageing
Volume: 22 Issue: 11
Author(s): Madalena Martins, Nuno G. Azoia, Ana C. Carvalho, Carla Silva, Teresa Matamá, Andreia C. Gomes and Artur Cavaco-Paulo
Affiliation:
Keywords: Diffusion, immunoassay, protease, inhibitory peptide, nanodispersion, proteolysis.
Abstract: Ageing and skin exposure to UV radiation induces production and activation of matrix metalloproteinases (MMPs) and human neutrophil elastase (HNE). These enzymes are known to break down the extracellular matrix (ECM) which leads to wrinkle formation. Here, we demonstrated the potential of a solid-in-oil nanodispersion containing a competitive inhibitor peptide of HNE mixed with hyaluronic acid (HA), displaying 158 nm of mean diameter, to protect the skin against the ageing effects. Western blot analysis demonstrated that activation of MMP-1 in fibroblasts by HNE treatment is inhibited by the solid-in-oil nanodispersion containing the peptide and HA. The results clearly demonstrate that solid-in-oil nanodispersion containing the HNE inhibitor peptide is a promising strategy for anti-ageing effects. This effect can be seen particularly by ECM regulation by affecting fibroblasts. The formulation also enhances the formation of thicker bundles of actin filaments.
Export Options
About this article
Cite this article as:
Martins Madalena, Azoia G. Nuno, Carvalho C. Ana, Silva Carla, Matamá Teresa, Gomes C. Andreia and Cavaco-Paulo Artur, Assessment of a Protease Inhibitor Peptide for Anti-Ageing, Protein & Peptide Letters 2015; 22 (11) . https://dx.doi.org/10.2174/0929866522666150907111351
DOI https://dx.doi.org/10.2174/0929866522666150907111351 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies
Current Pharmaceutical Design Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations
Current Molecular Medicine Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Mitochondrial Uncoupler Proteins
Current Enzyme Inhibition Patent Selections
Recent Patents on Cardiovascular Drug Discovery The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry Metformin in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry Physical and Mental Functions of Cardiovascular Diseased Patients Decrease During the State of Emergency Initiated by the COVID-19 Pandemic in Japan
Reviews on Recent Clinical Trials Drug Interactions between Non-Steroidal Anti-Inflammatory Drugs and Cardiovascular Treatments (Except Anti-Agregant Therapy)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Mitochondrial Dysfunction in the Pathophysiology of Bipolar Disorder: Effects of Pharmacotherapy
Mini-Reviews in Medicinal Chemistry Designing Peptidomimetics
Current Topics in Medicinal Chemistry Clinical Applications of Cardiac Multi-Slice Computed Tomography
Current Medical Imaging Patent Selections
Recent Patents on Cardiovascular Drug Discovery Cardiovascular Disease and Inflammation: Novel Biomarkers of Inflammation and Endothelial Activation
Vascular Disease Prevention (Discontinued) Molecular Basis of Cardioprotection by Erythropoietin
Current Molecular Pharmacology Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Lack of Association Between Prokineticin 2 Gene and Japanese Methamphetamine Dependence
Current Neuropharmacology